Live Breaking News & Updates on Dave Schoneker

Stay updated with breaking news from Dave schoneker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Incorporating Excipients Into QbD Studies For Drug Development — An Introduction


Incorporating Excipients Into QbD Studies For Drug Development — An Introduction
By Brian Carlin (DFE Pharma), Chris Moreton (FinnBrit Consulting), Dave Schoneker (Black Diamond Consulting), Katherine Ulman (KLU Consulting), Joseph Zeleznik (IMCD)
This article is the first in a three-part series based on information from the new guide Incorporation of Pharmaceutical Excipients into Product Development using Quality-by-Design
, published by the International Pharmaceutical Excipients Council Federation (IPEC Federation).
1
The International Conference on Harmonization’s (ICH) guidelines related to quality by design (QbD) primarily ICH Q8, as well as Q9, Q10, Q11, and Q12
2-6 are high level and focus on the active pharmaceutical ingredient (API) and finished drug product. Applying API logic to excipients can lead to counterproductive adaptations inconsistent with QbD principles. ....

De Bourgogne , Region Flamande , United States , United Kingdom , Bruxelles Capitale , City Of , Merriam Webster , Edwards Deming , Brian Carlin , Katherine Ulman , Joseph Zeleznik , Chris Moreton Finnbrit , Tripartite Guideline Pharmaceutical Development , Tripartite Guideline Development , Imperial College , International Conference On Harmonization , International Pharmaceutical Excipients Council Federation , Product Development , International Pharmaceutical Excipient Council Qualification Of Excipients , International Pharmaceutical Excipients Council , Silversteini Pharmaceutical Technology Feb , Chris Moreton , Finnbrit Consulting , Dave Schoneker , Black Diamond Consulting , Pharmaceutical Excipients ,